UpHealth, Inc.
UPH · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | 28.3% | 2,194.2% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | 44.2% | 35.2% | 78.1% | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $0 | $0 | – |
| SG&A Expenses | $0 | $0 | $0 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $0 | $0 | $0 | – |
| Operating Income | -$0 | -$0 | -$0 | – |
| % Margin | -15.8% | -36.2% | -35.7% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | – |
| Pre-Tax Income | -$0 | -$0 | -$0 | – |
| Tax Expense | -$0 | -$0 | $0 | – |
| Net Income | -$0 | -$0 | -$0 | – |
| % Margin | -140.4% | -274.9% | -39% | – |
| EPS | -15.17 | -31.8 | -0.4 | – |
| % Growth | 52.3% | -7,850% | – | – |
| EPS Diluted | -15.17 | -31.8 | -0.4 | – |
| Weighted Avg Shares Out | 0 | 0 | 0 | – |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $0 | $0 | $0 | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | -98.9% | -231.3% | -31.1% | – |